Image de couverture de livre

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors

Therapeutic drug monitoring (TDM) is uncommon in child and adolescent psychiatry, particularly for selective serotonin reuptake inhibitors (SSRIs)-the first-line pharmacologic treatments for depressive and anxiety disorders. However, TDM in children and adolescents offers the opportunity to leverage...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jeffrey R. Strawn (Auteur), Ethan A. Poweleit (Auteur), Chakradhara Rao S. Uppugunduri (Auteur), Laura B. Ramsey (Auteur)
Format:	Livre
Publié:	Frontiers Media S.A., 2021-10-01T00:00:00Z.
Sujets:	article
Accès en ligne:	Connect to this object online.
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Selective Serotonin Reuptake Inhibitor Pharmacokinetics During Pregnancy: Clinical and Research Implications
par: Ethan A. Poweleit, et autres
Publié: (2022)

Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders
par: Stacey L. Aldrich, et autres
Publié: (2019)

Talking 'bout digitality
par: Stefan Meier, et autres
Publié: (2023)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
par: Chad Compagner, et autres
Publié: (2021)

Tutorial on model selection and validation of model input into precision dosing software for model‐informed precision dosing
par: Zachary L. Taylor, et autres
Publié: (2023)

Suicide attempt with selective serotonin reuptake inhibitor antidepressants
par: Sandra Cuenca Carcelén, et autres
Publié: (2021)

Selective Serotonin Reuptake Inhibitors and Adverse Effects: A Narrative Review
par: Amber N. Edinoff, et autres
Publié: (2021)

Selective Serotonin Reuptake Inhibitors and Clozapine: Clinically Relevant Interactions and Considerations
par: Amber N. Edinoff, et autres
Publié: (2021)

Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
par: Orna Diav-Citrin, et autres
Publié: (2012)

Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
par: Thanh Thanh L. Nguyen, et autres
Publié: (2021)

Decreased Growth with Serotonin Reuptake Inhibitors
par: J Gordon Millichap
Publié: (2002)

The Effects of Selective Serotonin-Reuptake Inhibitor on Visual Evoked Potential in Rats
par: Yoshihiro Iwamura, et autres
Publié: (2004)

Target to treatment: A charge to develop biomarkers of response and tolerability in child and adolescent psychiatry
par: Stephani L. Stancil, et autres
Publié: (2022)

Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19
par: Mahsa Asadi Anar, et autres
Publié: (2022)

Can a Selective Serotonin Reuptake Inhibitor Act as a Glutamatergic Modulator?
par: Marcos Emilio Frizzo, PhD
Publié: (2017)

Selective serotonin reuptake inhibitors suppress sharp wave ripples in the ventral hippocampus
par: Hiromi Shiozaki, et autres
Publié: (2023)

Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
par: Patel H, et autres
Publié: (2015)

Teaching Patient Safety via a Structured Review of Medical Errors: A Novel Approach to Educating Residents About Medical Error, Disclosure, and Malpractice
par: Ethan Cumbler, et autres
Publié: (2007)

Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases
par: Diana Dubrall, et autres
Publié: (2023)

Role of selective serotonin reuptake inhibitors in prognosis dental implants: A retrospective study
par: Praveen Chandra, et autres
Publié: (2021)

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
par: James M Martinez, et autres
Publié: (2015)

Prenatal exposure to serotonin reuptake inhibitors: a case report
par: Solinas Agostina, et autres
Publié: (2010)

New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
par: David Fanelli, et autres
Publié: (2021)

Secondary and side effects of particular Selective Serotonin Reuptake Inhibitors (SSRIs) antidepressants - literature review
par: Ewa Krzewicka-Romaniuk, et autres
Publié: (2020)

A Bibliometric Analysis of the WoSCC Literature on the Use of Selective Serotonin Reuptake Inhibitors as Antidepressants
par: Li J, et autres
Publié: (2024)

Case-Control Study Examining the Association between Selective Serotonin Reuptake Inhibitors Use and Hepatocellular Carcinoma
par: Shih-Wei Lai, et autres
Publié: (2017)

Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org
par: Zachary L. Taylor, et autres
Publié: (2023)

The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
par: Raqeeb Mahmood, et autres
Publié: (2024)

The Risk of Acute Pancreatitis and Selective Serotonin Reuptake Inhibitors Use: A Meta-Analysis of Case-Control Studies
par: Shih-Wei Lai, et autres
Publié: (2020)

Case-Control Study Investigating the Association Between Use of Selective Serotonin Reuptake Inhibitors and Pulmonary Tuberculosis in Taiwan
par: Kao-Chi Cheng, et autres
Publié: (2019)

Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Stroke Rehabilitation: A Prospective Observational Pilot Cohort Study
par: See-Hwee Yeo, et autres
Publié: (2019)

Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues.
par: Ethan Budd Russo
Publié: (2016)

Risks of Digestive System Side-Effects of Selective Serotonin Reuptake Inhibitors in Patients with Depression: A Network Meta-Analysis
par: Wang Z, et autres
Publié: (2022)

Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice
par: Naoki Amada, et autres
Publié: (2023)

Comparative efficacy and acceptability of selective serotonin reuptake inhibitor antidepressants for binge eating disorder: A network meta-analysis
par: Hanying Duan, et autres
Publié: (2022)

Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects
par: Shin D, et autres
Publié: (2017)

Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection
par: Pascal Le Corre, et autres
Publié: (2022)

The Effect of Serotonin-Norepinephrine Reuptake Inhibitor Milnacipran on Anxiety-like Behaviors in Diabetic Mice
par: Tuhfatul Ulya, et autres
Publié: (2021)

Disposition and metabolism of [14C]-levomilnacipran, a serotonin and norepinephrine reuptake inhibitor, in humans, monkeys, and rats
par: Brunner V, et autres
Publié: (2015)

Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
par: Thibault eRenoir
Publié: (2013)